Publication: Estudio de metilación en lesiones orales potencialmente malignizables. Estudio piloto
Loading...
Official URL
Full text at PDC
Publication Date
2011
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citations
Exportar
Abstract
Description
UCM subjects
Unesco subjects
Keywords
Citation
1. Oliver RJ, Dearing J, Hindle I. Oral cancer in young adults: Report of three cases and review of the literature. Br Dent J 2000; 188: 362-5.
2. Sánchez-Céspedes M, Esteller M, Wu L et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Can Res 2000; 60: 892-5.
3. Scully C. Oncogenes, tumor suppressors and viruses in oral squamous carcinoma. J Oral Pathol Med 1993; 22: 337-47.
4. Femiano F, Scully C. DNA cytometry of oral leukoplakia and oral lichen planus. Med Oral Patol Oral Cir Bucal 2005; 10(1): 9-14.
5. Kulkarni V, Saranath D. Concurrent hipermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues.
Oral Oncol 2004; 40: 145-53.
6. Lin WJ, Jiang RS, Wu SH, Chen FJ, Liu SH. Smoking, Alcohol, and Betel Quid and Oral Cancer: A Prospective Cohort Study. J Oncol 2011; 17:1-5.
7. Banoczy J, Gintner Z, Dombi C. Tobacco use and oral leukoplakia. J Dent Educ 2001; 65: 322-7.
8. Hasegawa M, Heather HN, Peters E, Ringstrom E, Posner M and Kelsey KT. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene
2002; 21: 4231-6.
9. Balderas-Loaeza A, Anaya-Saavedra G, Ramirez-Amador VA et al: Human papillomavirus-16 DNA methylation patterns support a casual association of the virus with oral squamous cell carcinoma. Int J Cancer 2007; 120: 2165-9.
10. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132(1): 6-13.
11. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-28.
12. Shaw R. The epigenetics of oral cáncer. Int J Oral Maxillofac Surg 2006; 35(2): 101-8.
13. Antequera F, Boyes J, Bird A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 1990; 62(3): 503-14.
14. Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 2006; 7 (1): 77-82.
15. Viet CT, Jordan RC, Schmidt BL. DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer. J Calif Dent Assoc 2007; 35(12): 844-9.
16. Rosas S, Kock W, Carvalho MG et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in
tumours and saliva of head and neck cancer patients. Cancer Research 2001; 61: 939-42.
17. Nawroz H, Koch W, Anker P, Stroun M and Sidrannsky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996; 2(9); 972-4.
18. Shapiro CM, Bitran JD, Shapiro RA. Remission of metastatic adenocarcinoma of the colon. JAMA 1983; 250(18): 2503-4.
19. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977; 37(3): 646-50.
20. Kato K, Hara A, Kuno T et al: Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinoma and the surrounding normal mucosa. J
Cancer Res Clin Oncol 2006; 132 (11): 735-43.
21. Guo XL, Sun SZ, Wang WX, Wei FC, Yu HB, Ma BL. Alterations of p16INK4a tumour suppressor gene in mucoepidermoid carcinoma of the salivary glands. Int J
Maxillofac Surg 2007; 36(4): 350-3.
22. Roth M, Abnet CC, Hu N et al. p16, MGMT, RARβ2, CLDN3 and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions. Oncol Rep 2007; 15: 1591-7.
23. Ruesga MT, Acha-Sagredo A, Rodríguez MJ et al. p16INK4a promoter hypermethylation in oral scrapings of oral squamous cell carcinoma risk patients. Cancer Lett 2007; 250: 140-5.
24. López M, Aguirre JM, Cuevas N et al. Gene promoter hypermethylation in oral rinses of leukoplakia patients-a diagnostic and/or prognostic tool?. Eur J Cancer 2003;
39: 2306-9.
25. Takeshima M, Saitoh M, Kusano K et al. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in
Sri Lanka. J Oral Pathol Med 2008; 37(8): 475-9.
26. Hall GL, Shaw RJ, Field EA et al. P16 promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia. Can Epid Biomarkers Prev 2008; 17(8): 2174-9.
27. Shapiro CM, Bitran JD, Shapiro RA. Remission of metastatic adenocarcinoma of the colon. JAMA 1983; 250(18): 2503-4.
28. Sawhney M, Rohatgi N, Kaur J et al. MGMT expression in oral precancerous and cancerous lesions: Correlation with progression, nodal metastasis and poor prognosis.
Oral Oncol 2007; 43: 515-22.
29. Lee ES, Issa JP, Roberts DB et al. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: Comparison with methylationspecific PCR technique and clinical significance. Clin Cancer Res 2008; 14(9); 2664-72.
30. Huang J, Shen W, Li B, Liao S, Zhang W, Cheng N. Molecular and inmunohistochemical study of the inactivation of the p16 gene in primary hepatocellular carcinoma. Clin Med J 2000; 31 (8): 443-9.
31. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum
DNA from non-small cell lung cancer patients. Cancer Res 1999; 59(1): 67-70.
32. Von Zeidler SV, Miracca EC, Nagai MA, Birman EG. Hypermethylation of the p16 gene in normal oral mucosa of smokers. Int J Mol Med 2004; 14: 807-11.
33. Amagasa T, Yamashiro M, Ishikawa H. Oral leukoplakia related to malignant transformation. Oral Sci Int 2006; 3:45–55.
34. Herman JG, Grafft JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci 1996; 93: 9821-6.
35. Derks S, Lentjes MH, Hellebrekers DM, de Bruïne AP, Herman JG, van Engeland M. Methylation-specific PCR unraveled. Cell Oncol 2004;26(5-6):291-9.
36. Campo-Trapero J, Cano-Sánchez J, Palacios-Sánchez B, Sánchez-Gutierrez JJ, Gonzalez-Moles MA, Bascones-Martinez A. Update on Molecular Pathology in Oral Cancer and Precancer. Anticancer Res 2008; 28: 1197-208.
37. Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am. J. Pathol 2003; 163: 1101-7.
38. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W. High frequency of p16 (CDKN2⁄MTS-1⁄INK4A) inactivation in head and neck squamous cell carcinoma.
Cancer Res 1996; 56: 3630–3.